These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29547110)

  • 21. The science of neuropsychiatry: past, present, and future.
    Arzy S; Danziger S
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):392-5. PubMed ID: 26037864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using our brains: the findings, flaws, and future of postmortem studies of psychiatric disorders.
    Harrison PJ
    Biol Psychiatry; 2011 Jan; 69(2):102-3. PubMed ID: 21183008
    [No Abstract]   [Full Text] [Related]  

  • 23. On the role of asymmetric frontal cortical activity in approach and withdrawal motivation: An updated review of the evidence.
    Harmon-Jones E; Gable PA
    Psychophysiology; 2018 Jan; 55(1):. PubMed ID: 28459501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal models for neuropsychiatric disorders: prospects for circuit intervention.
    Kaiser T; Zhou Y; Feng G
    Curr Opin Neurobiol; 2017 Aug; 45():59-65. PubMed ID: 28419975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dual origin hypothesis: an evolutionary brain-behavior framework for analyzing psychiatric disorders.
    Giaccio RG
    Neurosci Biobehav Rev; 2006; 30(4):526-50. PubMed ID: 16356547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epilepsy, behavior, and neuropsychiatry.
    Cavanna AE
    Epilepsy Behav; 2014 Nov; 40():78. PubMed ID: 25278318
    [No Abstract]   [Full Text] [Related]  

  • 27. Computational Phenotyping in Psychiatry: A Worked Example.
    Schwartenbeck P; Friston K
    eNeuro; 2016; 3(4):. PubMed ID: 27517087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approaches to the study of postmortem brain in psychiatric illness: old limitations and new challenges.
    McCullumsmith RE; Meador-Woodruff JH
    Biol Psychiatry; 2011 Jan; 69(2):127-33. PubMed ID: 21094488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression.
    Archer T; Kostrzewa RM; Beninger RJ; Palomo T
    Neurotox Res; 2010 Nov; 18(3-4):287-305. PubMed ID: 20237881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging story of emerging technologies in neuropsychiatry.
    Coffey MJ; Coffey CE
    Dialogues Clin Neurosci; 2016 Jun; 18(2):127-34. PubMed ID: 27489452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimaging and psychiatry: the long road from bench to bedside.
    Mayberg HS
    Hastings Cent Rep; 2014; Spec No():S31-6. PubMed ID: 24634083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apathy, anhedonia, and psychomotor retardation in elderly psychiatric patients and healthy elderly individuals.
    Lampe IK; Kahn RS; Heeren TJ
    J Geriatr Psychiatry Neurol; 2001; 14(1):11-6. PubMed ID: 11281310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The three-dimensional approach to neuropsychiatric assessment.
    Marin RS
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):384-93. PubMed ID: 23224445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nosological position of apathy in clinical practice.
    Starkstein SE; Leentjens AF
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1088-92. PubMed ID: 18187477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling brain emergent behaviours through coevolution of neural agents.
    Maniadakis M; Trahanias P
    Neural Netw; 2006 Jun; 19(5):705-20. PubMed ID: 15990275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantifying motivational deficits and apathy: a review of the literature.
    Weiser M; Garibaldi G
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1060-81. PubMed ID: 25863434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The forthcoming DSM-5, critical care medicine, and pediatric neuropsychiatry: which new concepts do we need?
    Schieveld JN; Wolters AM; Blankespoor RJ; van de Riet EH; Vos GD; Leroy PL; van Os J
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):111-4. PubMed ID: 23686027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour.
    Brown RG; Pluck G
    Trends Neurosci; 2000 Sep; 23(9):412-7. PubMed ID: 10941190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of dopamine in the pathophysiology and treatment of apathy.
    Chong TT; Husain M
    Prog Brain Res; 2016; 229():389-426. PubMed ID: 27926449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction. Animal models of neuropsychiatric disorders.
    Novak MA; Meyer JS
    ILAR J; 2014; 55(2):217-20. PubMed ID: 25225301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.